← Thomson Reuters Corporation Common Shares overview

Thomson Reuters Corporation Common Shares vs DXC Technology: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Thomson Reuters Corporation Common Shares (TRI)

Q3 2026
▲4

TRI Rallies on AI Restructuring, KKR Print Deal, and Government Contract

  • AI-focused restructuring Thomson Reuters announced it will cut up to 500 engineering roles and create over 250 senior AI positions, aiming to accelerate AI-driven growth in legal, tax, and regulatory workflows. Management expects a notable revenue improvement this year, boosting investor confidence.

    This is a major strategic shift that directly impacts future growth and profitability.

  • KKR joint venture for Global Print Thomson Reuters sold a 51% stake in its Global Print business to KKR for about $500 million, retaining 49% and editorial control. The deal brings cash and focuses the company on higher-growth digital and AI areas.

    This capital move strengthens the balance sheet and sharpens strategic focus.

  • Undervaluation after AI pivot An analysis suggests Thomson Reuters stock may be undervalued, trading at 24.4 times earnings versus a fair P/E of 42.0. Despite a 55.9% drop over the past year, the AI restructuring and print deal could support long-term profitability, though execution risk remains.

    This highlights potential upside and addresses the stock's recent weakness.

  • $125M ICE contract for CLEAR Thomson Reuters secured a five-year, $125 million contract with ICE for its CLEAR investigative product, providing access to credit card application data. This adds stable government revenue but raises privacy concerns and potential regulatory scrutiny.

    This new contract demonstrates strong demand for its data services and adds recurring revenue.

July 2026
▲4

TRI Rallies on AI Restructuring, KKR Print Deal, and Government Contract

  • AI-focused restructuring Thomson Reuters announced it will cut up to 500 engineering roles and create over 250 senior AI positions, aiming to accelerate AI-driven growth in legal, tax, and regulatory workflows. Management expects a notable revenue improvement this year, boosting investor confidence.

    This is a major strategic shift that directly impacts future growth and profitability.

  • KKR joint venture for Global Print Thomson Reuters sold a 51% stake in its Global Print business to KKR for about $500 million, retaining 49% and editorial control. The deal brings cash and focuses the company on higher-growth digital and AI areas.

    This capital move strengthens the balance sheet and sharpens strategic focus.

  • Undervaluation after AI pivot An analysis suggests Thomson Reuters stock may be undervalued, trading at 24.4 times earnings versus a fair P/E of 42.0. Despite a 55.9% drop over the past year, the AI restructuring and print deal could support long-term profitability, though execution risk remains.

    This highlights potential upside and addresses the stock's recent weakness.

  • $125M ICE contract for CLEAR Thomson Reuters secured a five-year, $125 million contract with ICE for its CLEAR investigative product, providing access to credit card application data. This adds stable government revenue but raises privacy concerns and potential regulatory scrutiny.

    This new contract demonstrates strong demand for its data services and adds recurring revenue.

Latest
▲4

TRI Rallies on AI Restructuring, KKR Print Deal, and Government Contract

  • AI-focused restructuring Thomson Reuters announced it will cut up to 500 engineering roles and create over 250 senior AI positions, aiming to accelerate AI-driven growth in legal, tax, and regulatory workflows. Management expects a notable revenue improvement this year, boosting investor confidence.

    This is a major strategic shift that directly impacts future growth and profitability.

  • KKR joint venture for Global Print Thomson Reuters sold a 51% stake in its Global Print business to KKR for about $500 million, retaining 49% and editorial control. The deal brings cash and focuses the company on higher-growth digital and AI areas.

    This capital move strengthens the balance sheet and sharpens strategic focus.

  • Undervaluation after AI pivot An analysis suggests Thomson Reuters stock may be undervalued, trading at 24.4 times earnings versus a fair P/E of 42.0. Despite a 55.9% drop over the past year, the AI restructuring and print deal could support long-term profitability, though execution risk remains.

    This highlights potential upside and addresses the stock's recent weakness.

  • $125M ICE contract for CLEAR Thomson Reuters secured a five-year, $125 million contract with ICE for its CLEAR investigative product, providing access to credit card application data. This adds stable government revenue but raises privacy concerns and potential regulatory scrutiny.

    This new contract demonstrates strong demand for its data services and adds recurring revenue.

DXC Technology Co (DXC)

Q3 2026
▲2▼2

DXC's Weak Earnings and Legal Probe Weigh on Shares

  • Securities Fraud Investigation Pomerantz LLP is investigating DXC for possible securities fraud tied to its May 7 earnings miss, which already caused a 21% stock drop. The probe adds legal uncertainty and could lead to fines or lawsuits, making investors more cautious and pressuring the stock.

    This is a new legal risk that directly threatens DXC's finances and reputation, explaining recent price weakness.

  • Wins $213.56 Million in Trade Secrets Case DXC collected $213.56 million from Tata Consultancy Services after the Supreme Court upheld a trade secrets ruling. This cash boost strengthens DXC's balance sheet and shows it will defend its intellectual property, a positive for investors.

    This is a new, concrete financial gain that improves DXC's cash position and could support future investments.

  • Launches Private Cloud+ for Regulated Industries DXC launched Private Cloud+, a hybrid cloud solution for sensitive workloads in finance, healthcare, and government. This expands its product lineup and targets high-value clients, potentially boosting future revenue and showing innovation.

    This is a new product that could drive demand and revenue growth, a positive strategic move.

  • IBM Warning and Weak Q2 Earnings IBM's revenue warning signaled stalled enterprise deals, dragging DXC shares down 4.2%. Then DXC's Q2 adjusted EPS missed estimates by 11.3% and next-quarter revenue guidance was below expectations, sending shares down another 5.2%. These reinforce concerns about weak demand and execution.

    These are new negative developments that directly impact DXC's earnings and investor confidence, explaining recent price declines.

July 2026
▲2▼2

DXC's Weak Earnings and Legal Probe Weigh on Shares

  • Securities Fraud Investigation Pomerantz LLP is investigating DXC for possible securities fraud tied to its May 7 earnings miss, which already caused a 21% stock drop. The probe adds legal uncertainty and could lead to fines or lawsuits, making investors more cautious and pressuring the stock.

    This is a new legal risk that directly threatens DXC's finances and reputation, explaining recent price weakness.

  • Wins $213.56 Million in Trade Secrets Case DXC collected $213.56 million from Tata Consultancy Services after the Supreme Court upheld a trade secrets ruling. This cash boost strengthens DXC's balance sheet and shows it will defend its intellectual property, a positive for investors.

    This is a new, concrete financial gain that improves DXC's cash position and could support future investments.

  • Launches Private Cloud+ for Regulated Industries DXC launched Private Cloud+, a hybrid cloud solution for sensitive workloads in finance, healthcare, and government. This expands its product lineup and targets high-value clients, potentially boosting future revenue and showing innovation.

    This is a new product that could drive demand and revenue growth, a positive strategic move.

  • IBM Warning and Weak Q2 Earnings IBM's revenue warning signaled stalled enterprise deals, dragging DXC shares down 4.2%. Then DXC's Q2 adjusted EPS missed estimates by 11.3% and next-quarter revenue guidance was below expectations, sending shares down another 5.2%. These reinforce concerns about weak demand and execution.

    These are new negative developments that directly impact DXC's earnings and investor confidence, explaining recent price declines.

Latest
▲2▼2

DXC's Weak Earnings and Legal Probe Weigh on Shares

  • Securities Fraud Investigation Pomerantz LLP is investigating DXC for possible securities fraud tied to its May 7 earnings miss, which already caused a 21% stock drop. The probe adds legal uncertainty and could lead to fines or lawsuits, making investors more cautious and pressuring the stock.

    This is a new legal risk that directly threatens DXC's finances and reputation, explaining recent price weakness.

  • Wins $213.56 Million in Trade Secrets Case DXC collected $213.56 million from Tata Consultancy Services after the Supreme Court upheld a trade secrets ruling. This cash boost strengthens DXC's balance sheet and shows it will defend its intellectual property, a positive for investors.

    This is a new, concrete financial gain that improves DXC's cash position and could support future investments.

  • Launches Private Cloud+ for Regulated Industries DXC launched Private Cloud+, a hybrid cloud solution for sensitive workloads in finance, healthcare, and government. This expands its product lineup and targets high-value clients, potentially boosting future revenue and showing innovation.

    This is a new product that could drive demand and revenue growth, a positive strategic move.

  • IBM Warning and Weak Q2 Earnings IBM's revenue warning signaled stalled enterprise deals, dragging DXC shares down 4.2%. Then DXC's Q2 adjusted EPS missed estimates by 11.3% and next-quarter revenue guidance was below expectations, sending shares down another 5.2%. These reinforce concerns about weak demand and execution.

    These are new negative developments that directly impact DXC's earnings and investor confidence, explaining recent price declines.